Company Filing History:
6 out of 3,684 
4 out of 183 
Years Active: 2017-2024
Title: Innovations of Brad D Maxwell
Introduction
Brad D Maxwell is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit platelet aggregation. With a total of six patents to his name, Maxwell's work has the potential to impact the treatment of thromboembolic disorders.
Latest Patents
One of Maxwell's latest patents focuses on imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation. The invention provides thiazole compounds of a specific formula, which can be used as medicaments for treating or preventing thromboembolic disorders. These compounds are designed to inhibit platelet aggregation, showcasing Maxwell's innovative approach to addressing critical health issues.
Career Highlights
Throughout his career, Brad D Maxwell has worked with prominent organizations such as Bristol-Myers Squibb Company and Université De Montréal. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Maxwell has had the opportunity to work alongside notable colleagues, including Jacques Banville and Edward H Ruediger. These collaborations have enriched his research and expanded the scope of his inventions.
Conclusion
Brad D Maxwell's contributions to the field of medicinal chemistry through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to pave the way for new treatments in the medical community.